www.2020optimeyes.ca
Innovation Type:
Therapeutics
Cancer Type:
Multiple
Funding Stage:
pre-seed
Fund:
Prospects
Next-generation mucoadhesive micelle nanoparticle platform for intrathecal delivery of chemotherapy and small-molecule drugs directly to mucosal surfaces.

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.